Zulong Liu

801 total citations
22 papers, 651 citations indexed

About

Zulong Liu is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Zulong Liu has authored 22 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Epidemiology. Recurrent topics in Zulong Liu's work include Quinazolinone synthesis and applications (3 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zulong Liu is often cited by papers focused on Quinazolinone synthesis and applications (3 papers), RNA modifications and cancer (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zulong Liu collaborates with scholars based in China, United States and Japan. Zulong Liu's co-authors include Xianfeng Zhou, Yu Gou, Danfeng Yao, Weibin Shi, Rui Chen, Chenghai Liu, Aiping Li, Jianwei Zhou, Qiang Yu and Li Shen and has published in prestigious journals such as Nature Communications, Hepatology and Free Radical Biology and Medicine.

In The Last Decade

Zulong Liu

22 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zulong Liu China 15 379 112 82 74 63 22 651
Shijia Wu China 10 482 1.3× 80 0.7× 116 1.4× 44 0.6× 51 0.8× 15 777
Hye-Yeon Choi South Korea 9 471 1.2× 118 1.1× 81 1.0× 37 0.5× 58 0.9× 10 727
Nina Xue China 18 508 1.3× 143 1.3× 94 1.1× 42 0.6× 83 1.3× 46 896
Jin Won Yang South Korea 19 592 1.6× 140 1.3× 123 1.5× 72 1.0× 53 0.8× 37 1.0k
Tomomi Masuda Japan 17 453 1.2× 111 1.0× 34 0.4× 80 1.1× 49 0.8× 43 838
Yong Kee Kim South Korea 22 615 1.6× 176 1.6× 132 1.6× 38 0.5× 62 1.0× 34 944
Julie A. Arlotti United States 15 458 1.2× 89 0.8× 104 1.3× 83 1.1× 86 1.4× 19 775
Baoping Jiang China 17 454 1.2× 65 0.6× 145 1.8× 74 1.0× 31 0.5× 33 852
Minsun Chang South Korea 17 588 1.6× 121 1.1× 160 2.0× 64 0.9× 85 1.3× 46 965

Countries citing papers authored by Zulong Liu

Since Specialization
Citations

This map shows the geographic impact of Zulong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zulong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zulong Liu more than expected).

Fields of papers citing papers by Zulong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zulong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zulong Liu. The network helps show where Zulong Liu may publish in the future.

Co-authorship network of co-authors of Zulong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zulong Liu. A scholar is included among the top collaborators of Zulong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zulong Liu. Zulong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Po‐Shun, Zulong Liu, Abdullah F. U. H. Saeed, et al.. (2024). Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis. Cancer Letters. 589. 216827–216827. 10 indexed citations
2.
Wang, Po‐Shun, Zulong Liu, Jie Xie, et al.. (2024). Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis. Environment International. 185. 108494–108494. 14 indexed citations
3.
4.
Wang, Zhishan, Zulong Liu, Po‐Shun Wang, et al.. (2023). Epigenetic downregulation of O6-methylguanine-DNA methyltransferase contributes to chronic hexavalent chromium exposure-caused genotoxic effect and cell transformation. Environmental Pollution. 341. 122978–122978. 9 indexed citations
5.
Zhang, Jie, Zulong Liu, & Jianhang Jia. (2021). Mechanisms of Smoothened Regulation in Hedgehog Signaling. Cells. 10(8). 2138–2138. 27 indexed citations
6.
Tripathi, R. P., Zulong Liu, Aditi Jain, et al.. (2020). Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling. Nature Communications. 11(1). 5463–5463. 33 indexed citations
7.
Guo, Tao, Zulong Liu, Qiang Zhao, Zhimin Zhao, & Chenghai Liu. (2018). A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo. Acta Pharmacologica Sinica. 39(9). 1483–1492. 29 indexed citations
8.
Tripathi, R. P., Zulong Liu, & Rina Plattner. (2018). Enabling Tumor Growth and Progression: Recent Progress in Unraveling the Functions of ABL Kinases in Solid Tumor Cells. Current Pharmacology Reports. 4(5). 367–379. 12 indexed citations
9.
Liu, Zulong, Hengrui Zhu, Shi‐Jin Qu, et al.. (2017). Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein. Anti-Cancer Agents in Medicinal Chemistry. 18(2). 286–294. 6 indexed citations
10.
Jin, Xiaofeng, et al.. (2015). Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC-7721 cells. Oncology Letters. 11(2). 1173–1178. 13 indexed citations
11.
Peng, Yuan, Yanyan Tao, Qinglan Wang, et al.. (2014). Ergosterol Is the Active Compound of Cultured Mycelium Cordyceps sinensis on Antiliver Fibrosis. Evidence-based Complementary and Alternative Medicine. 2014(1). 537234–537234. 21 indexed citations
12.
Tao, Yanyan, et al.. (2014). Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis. BMC Complementary and Alternative Medicine. 14(1). 449–449. 35 indexed citations
13.
Zhu, Hengrui, Zulong Liu, Junhua Liu, et al.. (2012). Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells. European Journal of Pharmacology. 696(1-3). 43–53. 44 indexed citations
14.
Liu, Zulong, Wei Tian, Yong Wang, et al.. (2012). A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule. Acta Pharmacologica Sinica. 33(2). 261–270. 29 indexed citations
15.
Liu, Guoyuan, Songmin Jiang, Chenji Wang, et al.. (2011). Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Hepatology. 55(6). 1830–1839. 47 indexed citations
17.
Chen, Hairong, Jin Bai, Jian Ye, et al.. (2007). JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cellular Signalling. 19(6). 1315–1327. 57 indexed citations
18.
Chen, Rui, Weihua Qiu, Zulong Liu, et al.. (2007). Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]pyrene and hydrogen peroxide. Free Radical Biology and Medicine. 42(11). 1704–1714. 48 indexed citations
19.
Liu, Zulong, et al.. (2006). JWA IS REQUIRED FOR THE ANTIPROLIFERATIVE AND PRO‐APOPTOTIC EFFECTS OF ALL‐TRANS RETINOIC ACID IN HELA CELLS. Clinical and Experimental Pharmacology and Physiology. 33(9). 816–824. 19 indexed citations
20.
Yao, Danfeng, et al.. (2005). Fatty acid-mediated intracellular iron translocation: A synergistic mechanism of oxidative injury. Free Radical Biology and Medicine. 39(10). 1385–1398. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026